Transcriptomics

Dataset Information

0

RNA-sequencing analysis of aneurysmal tissues with or without treatment of targeted nanotherapy.

ABSTRACT: Our study represents the first detailed analysis of aneurysmal tissues with or without our targeted nanotherapy, generated by RNA-seq technology. The optimized data analysis workflows reported here should provide a framework for comparative investigations of expression profiles.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE208025 | GEO | 2025/07/12

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics RNA-sequencing analysis of aneurysmal tissues with or without treatment of targeted nanotherapy.
| PRJNA858026 | ENA
Transcriptomics RNA sequencing of wild-type and TRα (-/-) hindlimb with and without T3 Treatment
2022-07-19 | GSE193364 | GEO
Transcriptomics RNA sequencing of wild-type and TRα (-/-) intestine with and without T3 Treatment.
2021-11-29 | GSE150487 | GEO
Genomics ChIP sequencing of wild-type, TRαLKO, TRβKO intestine at stage 54 with and without T3 treratment.
2024-12-26 | GSE269046 | GEO
Genomics ChIP sequencing of wild-type and TRα (-/-) hindlimb with and without T3 Treatment
2022-07-19 | GSE193363 | GEO
Genomics ChIP sequencing of wild-type and TRα (-/-) tail with and without T3 treatment.
2025-01-07 | GSE195932 | GEO
Genomics Altered microRNA expression: Control vs. Intracranial Aneurysmal Tissues
2020-11-21 | GSE161870 | GEO
Transcriptomics Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and L3mbtl2 cKO Testicular Transcriptomes
2018-08-01 | GSE109921 | GEO
Transcriptomics RNA sequencing of wild-type liver at stage 54, stage 61, stage 66 and T3 treated liver.
2023-01-31 | GSE201168 | GEO
Transcriptomics Metabolomic Rewiring in Endocrine Therapy-Resistant Estrogen Receptor Positive Breast Cancer
2023-10-25 | GSE240393 | GEO